Rochester Scientists Target Early Vision Loss in AMD

Researchers at University of Rochester Medicine received NIH funding to develop a breakthrough treatment that could stop macular degeneration before it steals vision from millions of older adults.

The new therapy targets a protein that drives the disease at its earliest stages.